ckd and semaglutide just got FDA-approved for kidney disease. This changes everything., January 2025. The FDA approved semaglutide (Ozempic/Wegovy) for a new indication: reducing kidney disease progression in Effects of Semaglutide on CKD

So, if youre trying to lose weight, Semaglutide is a good option

Inhibition of glutathione S-transferases by antimalarial drugs possible implications for circumventing anticancer drug resistance

While we typically get these vitamins through a healthy diet, sometimes we may need an extra boost

PA criteria match the Wegovy obesity pathway: BMI 30+, or 27+ with comorbidity, 6-month documented weight management program, prescriber attestation, age 18+

(13) These findings suggest a promising osteogenic role for GLP-1 therapies, especially in metabolic disease contexts

Instead of remaining as individual, functional molecules, peptides in a poorly stored solution can clump together